Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Luger

Showing results (211-220 of 311) with videos related to

Pageof 32
Sort By:
Genome Biology|September 28, 2014
Dynamic evolution of clonal epialleles revealed by methcloneSheng Li, Francine Garrett-Bakelman, Alexander E Perl, et al.
Transplantation|January 12, 1999
Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneysC F Bryan, C F Shield, P W Nelson, et al.
Blood|November 5, 2005
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulationDavid L Porter, Bruce L Levine, Nancy Bunin, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
The involvement of prostaglandins in tumorigenesis, tumor-induced osteolysis and bone cancer painM C Sabino, J R Ghilardi, K J Feia, et al.
Transplantation and Cellular Therapy|August 2, 2021
Characterization of Pericarditis following Allogeneic Hematopoietic Cell TransplantationCraig W Freyer, Michael Fradley, David Madnick, et al.
Transplantation|March 21, 1998
Influence of the Rh (D) blood group system on graft survival in renal transplantationC F Bryan, S I Mitchell, H M Lin, et al.
American Journal of Hematology|July 29, 2016
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXIIAnita J Kumar, Phyllis A Gimotty, Joel M Gelfand, et al.
Transplantation|February 11, 1998
Ten-year experience in transplantation of A2 kidneys into B and O recipientsP W Nelson, M D Landreneau, A M Luger, et al.
Blood|November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemiaAdele K Fielding, Jacob M Rowe, Georgina Buck, et al.
The Journal of Experimental Medicine|December 14, 2011
ETV6 mutations in early immature human T cell leukemiasPieter Van Vlierberghe, Alberto Ambesi-Impiombato, Arianne Perez-Garcia, et al.
Pageof 32

Showing results (211-220 of 311) with videos related to

Sort By:
Pageof 32
Genome Biology|September 28, 2014
Dynamic evolution of clonal epialleles revealed by methcloneSheng Li, Francine Garrett-Bakelman, Alexander E Perl, et al.
Transplantation|January 12, 1999
Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneysC F Bryan, C F Shield, P W Nelson, et al.
Blood|November 5, 2005
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulationDavid L Porter, Bruce L Levine, Nancy Bunin, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
The involvement of prostaglandins in tumorigenesis, tumor-induced osteolysis and bone cancer painM C Sabino, J R Ghilardi, K J Feia, et al.
Transplantation and Cellular Therapy|August 2, 2021
Characterization of Pericarditis following Allogeneic Hematopoietic Cell TransplantationCraig W Freyer, Michael Fradley, David Madnick, et al.
Transplantation|March 21, 1998
Influence of the Rh (D) blood group system on graft survival in renal transplantationC F Bryan, S I Mitchell, H M Lin, et al.
American Journal of Hematology|July 29, 2016
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXIIAnita J Kumar, Phyllis A Gimotty, Joel M Gelfand, et al.
Transplantation|February 11, 1998
Ten-year experience in transplantation of A2 kidneys into B and O recipientsP W Nelson, M D Landreneau, A M Luger, et al.
Blood|November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemiaAdele K Fielding, Jacob M Rowe, Georgina Buck, et al.
The Journal of Experimental Medicine|December 14, 2011
ETV6 mutations in early immature human T cell leukemiasPieter Van Vlierberghe, Alberto Ambesi-Impiombato, Arianne Perez-Garcia, et al.
Pageof 32